HIV and the spectrum of human disease

Journal of Pathology

Volumn 235, Issue 2, 2015, Pages 229-241

  Lucas, Sebastian ^a   Nelson, Ann Marie ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b Infectious Disease Pathology Joint Pathology Center   (United States)

Author keywords

AIDS; HIV; HIVp24; Immune activation; IRIS; Pathology; Review

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

AGING; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; BRAIN DISEASE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHILDHOOD DISEASE; CHRONIC DISEASE; DYSLIPIDEMIA; ENDOTHELIUM CELL; ENTEROPATHY; EPIDEMIC; FATTY LIVER; HEART DISEASE; HIGH RISK PATIENT; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULE DAMAGE; LACTIC ACIDOSIS; LIPODYSTROPHY; LIVER TOXICITY; LYMPHADENOPATHY; MALIGNANT NEOPLASTIC DISEASE; MATERNAL DISEASE; MONONUCLEAR CELL; MORTALITY; NEUROLOGIC DISEASE; NONHUMAN; PATHOGEN LOAD; PATHOGENESIS; PATHOLOGIST; PORTAL HYPERTENSION; RASH; SKIN ALLERGY; TISSUE INJURY; VIRUS TRANSMISSION; ANIMAL; BIOPSY; DRUG EFFECTS; GENETICS; HIV INFECTIONS; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOLOGY; MOLECULAR PATHOLOGY; PATHOGENICITY; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; T LYMPHOCYTE; TIME; TREATMENT OUTCOME; VIROLOGY; VIRULENCE;

ANIMALS; ANTI-HIV AGENTS; BIOPSY; HIV; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HOST-PATHOGEN INTERACTIONS; HUMANS; PATHOLOGY, MOLECULAR; PREDICTIVE VALUE OF TESTS; T-LYMPHOCYTES; TIME FACTORS; TREATMENT OUTCOME; VIROLOGY; VIRULENCE;

EID: 84917706265     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4449     Document Type: Article

References (41)

1. Pepin J. The Origins of AIDS. Cambridge University Press: Cambridge, 2011.
2. Maartens G, Celum C, Lewin SR. HIV infection: epidemiology, pathogenesis, treatment and prevention. Lancet 2014; 384: 258-271.
3. Centers for Disease Control. 1993 revised classifcation system for HIV infection and expanded surveillance case defnition for AIDS among adolescents and children. Mortal Morbid Wkly Rep 1992; 41: RR-17.
4. Smith CJ, Ryom L, Weber R, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet 2014; 384: 241-248.
5. Kaur DR. Donor-derived infection: epidemiology and outcomes. Curr Infect Dis Rep 2012; 14: 676-682.
6. Doitsh G, Galloway NLK, Geng X, et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 2014; 505: 509-514.
7. Moonim MT, Alarcon L, Freeman J, et al. Identifying HIV infection in diagnostic histopathology tissue samples-the role of HIV-1 p24 immunohistochemistry in identifying clinically unsuspected HIV infection: a 3-year analysis. Histopathology 2010; 56: 530-541.
8. Rayment M, Asboe D, Sullivan AK. HIV testing and management of newly diagnosed HIV. Br Med J 2014; 349: 27-32.
9. Bustinduy A, King C, Scott J, et al. HIV and schistosomiasis co-infection in African children. Lancet Infect Dis 2014; 14: 640-649.
10. Dai HL, Zhang M, Xiao ZC, et al. Pulmonary artery hypertension in HIV infection: a concise review. Heart Lung Circ 2014; 23: 299-302.
11. Goodyear-Smith F, Sharland M, Nadel S. Think Hickam's Dictum not Occam's Razor in paediatric HIV. BMJ Case Rep 2014; published online 18 March 2014; DOI:10.1136/bcr-2013-202029.
12. Gramolelli S, Schulz T. The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma. J Pathol 2015; 235: 368-380.
13. Worm SW, Bower M, Reiss P, et al. Non-AIDS defning cancers in the D:A:D study-time-trends and predictors of survival: a cohort study. BMC Infect Dis 2013; 13: 471.
14. Lucas SB. Causes of death in the HAART era. Curr Opin Infect Dis 2012; 25: 36-41.
15. Cox JA, Lukande RL, Nelson AM, et al. An autopsy study describing causes of death and comparing clinic-pathologic fndings among hospitalized patients in Kampala, Uganda. PLoS One 2012; 7: e33685.
16. Lowenthal ED, Bakeera-Kitaka S, Marukuritra T, et al. Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: a review of emerging challenges. Lancet Infect Dis 2014; 14: 627-639.
17. Ferrand RA, Desai SR, Hopkins C, et al. Chronic lung disease in adolescents with delayed diagnosis of vertically acquired HIV infection. Clin Infect Dis 2012; 55: 145-152.
18. Gerntholtz TE, Goetsch SJW, Katz I. HIV-related nephropathy: a South African experience. Kidney Int 2006; 69: 1885-1891.
19. Lucas SB, De Cock KM, Hounnou A, et al. Contribution of tuberculosis to slim disease in Africa. Br Med J 1994; 308: 1531-1533.
20. Soni S, Srirajaskanthan R, Lucas SB, et al. Lymphogranuloma venereum proctitis masquerading as infammatory bowel disease in 12 homosexual men. Aliment Pharmacol Ther 2010; 32: 59-65.
21. DuPont HL, Marshall GD. HIV-associated diarrhoea and wasting. Lancet 1995; 346: 352-356.
22. Ramos JM, Masia M, Duran R, et al. Idiopathic ileocolitis with perforation associated with HIV infection: thalidomide treatment. Int J STD AIDS 2012; 23: 830-832.
23. Escarcega RO, Franco JL, Mani BC, et al. Cardiovascular disease in patients with HIV infection. Int J Cardiol 2014; 175: 1-7.
24. + count-guided interruption of antiretroviral treatment. N Engl J Med 2006; 355: 2283-2296.
25. Shaboodien G, Maske C, Wainwright H, et al. Prevalence of myocarditis and cardiotropic virus infection in Africans with HIV-associated cardiomyopathy, idiopathic dilated cardiomyopathy and heart transplant recipients: a pilot study. Cardiovasc J Afr 2013; 24: 218-233.
26. Bell JE. An update on the neuropathology of HIV in the HAART era. Histopathology 2004; 45: 549-559.
27. Benjamin LA, Bryer A, Emsley HCA, et al. HIV infection and stroke: current perspectives and future directions. Lancet Infect Dis 2012; 11: 878-890.
28. Lucas SB. HIV infection. Viral infections. In Greenfeld's Neu-ropathology, 9th edn, Love S, et al. (eds). CRC Press: Boca Raton, Florida, USA, 2015 (in press).
29. + lymphocytes in HIV patients receiving cART. Brain Pathol 2013; DOI: 10.1111/bpa.12038.
30. Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007; 69: 1789-1799.
31. Garvey LJ, Pavese N, Politis M, et al. Increased microglial activation in neurologically asymptomatic HIV-infected patients receiving effective ART. AIDS 2014; 28: 67-72.
32. Rao VR, Ruiz AP, Prasad VR. Viral and cellular factors underlying neuropathogenesis in HIV-associated neurocognitive disorders (HAND). AIDS Res Ther 2014; 11: 13.
33. Ipp H, Zemlin AE, Erasmus RT, et al. Role of infammation in HIV-1 disease progression and prognosis. Crit Rev Clin Lab Sci 2014; 51: 98-111.
34. Graham SM, Mwilu R, Liles WC. Clinical utility of biomarkers of endothelial activation and coagulation for prognosis in HIV infection: a systematic review. Virulence 2013; 4: 564-571.
35. Lopez M, San Roman J, Estrada V, et al. Endothelial dysfunction in HIV infection-the role of circulating endothelial cells, microparti-cles, endothelial progenitor cells and macrophages. AIDS Rev 2012; 14: 223-230.
36. Wang H, Kotler DP. HIV enteropathy and aging: gastrointestinal immunity, mucosal epithelial barrier, and microbial translocation. Curr Opin HIV AIDS 2014; 9: 309-316.
37. Sampirez G, Guerrero D, Lopez M, et al. Prevalence of and risk factors for pulmonary abnormalities in HIV-infected patients treated with antiretroviral therapy. HIV Med 2014; 15: 321-329.
38. Hofman P, Nelson AM. The pathology induced by highly active antiretroviral therapy against human immunodefciency virus: an update. Curr Med Chem 2006; 13: 3121-3132.
39. Nunez M. Clinical syndromes and consequences of antiretroviral-related hepatotoxicity. Hepatology 2010; 52: 1143-1155.
40. French MA, Lenzo N, John N, et al. Immume restoration disease after the treatment of immunodefcient HIV-infected patients with highly active antiretroviral therapy. HIV Med 2005; 1: 107-115.
41. Deps P, Lucas SB, Porro AM, et al. Clinical and histological features of leprosy and HIV co-infection in Brazil. Clin Exp Dermatol 2013; 38: 470-477.